Allan Basbaum: third Editor-in-Chief of PAIN and finding joy in pain research.

Pain

Department of Anesthesia, University of Iowa, Iowa City, IA, United States.

Published: July 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Allan Basbaum entered the field of pain research as an undergraduate at McGill University shortly after Pat Wall and Ron Melzack proposed Gate Control Theory. He has not wandered far from the field since then. Although Allan believes that serendipity has played a significant role in his success, it is equally important that one's mind be prepared to recognize the import of an event or finding. Over the past 50+ years, Allan has established a research program that is characterized by sustained innovation, pursuit of important questions, perseverance, early adoption of new methodologies, a willingness to embrace unexpected findings, and an enthusiastic endorsement of collaboration. The result has been a highly productive research program that continues to consistently advance our understanding of pain processes and simultaneously provides a unique environment that trains young investigators in multidisciplinary research and the convergent testing of hypotheses with complementary methodologies. This Pain Essay that pays tribute to the third Editor-in-Chief of PAIN describes the evolution of Allan's research program to date including some of his most important contributions to our understanding of the processes of nociception in the spinal cord and brainstem, as well as more recent studies encompassing biomarkers for the affective component of the pain experience. It also describes how PAIN thrived during his tenure as Editor-in-Chief, while providing a window into his ebullient personality. For Allan, pain research continues to be a life-long vocation that provides as much fun and satisfaction as a hobby.

Download full-text PDF

Source
http://dx.doi.org/10.1097/j.pain.0000000000003758DOI Listing

Publication Analysis

Top Keywords

pain
9
allan basbaum
8
third editor-in-chief
8
editor-in-chief pain
8
allan
5
basbaum third
4
pain finding
4
finding joy
4
joy pain
4
pain allan
4

Similar Publications

Background: Laboratory animal veterinarians play a crucial role as a bridge between the ethical use of laboratory animals and the advancement of scientific and medical knowledge in biomedical research. They alleviate pain and reduce distress through veterinary care of laboratory animals. Additionally, they enhance animal welfare by creating environments that mimic natural habitats through environmental enrichment and social associations.

View Article and Find Full Text PDF

Background: Volatile anesthetics are gaining recognition for their benefits in long-term sedation of mechanically ventilated patients with bacterial pneumonia and acute respiratory distress syndrome. In addition to their sedative role, they also exhibit anti-bacterial and anti-inflammatory properties, though the mechanisms behind these effects remain only partially understood. In vitro studies examining the prolonged impact of volatile anesthetics on bacterial growth, inflammatory cytokine response, and surfactant proteins - key to maintaining lung homeostasis - are still lacking.

View Article and Find Full Text PDF

X-Linked Hypophosphatemia: Role of Fibroblast Growth Factor 23 on Human Skeletal Muscle-Derived Cells.

Calcif Tissue Int

September 2025

FirmoLab, Fondazione F.I.R.M.O. Onlus and Stabilimento Chimico Farmaceutico Militare (SCFM), 50141, Florence, Italy.

X-linked hypophosphatemia (XLH) is a rare and progressive disease, due to inactivating mutations in the phosphate-regulating endopeptidase homolog X-linked (PHEX) gene. These pathogenic variants result in elevated circulating levels of fibroblast growth factor 23 (FGF23), responsible for the main clinical manifestations of XLH, such as hypophosphatemia, skeletal deformities, and mineralization defects. However, XLH also involves muscular disorders (muscle weakness, pain, reduced muscle density, peak strength, and power).

View Article and Find Full Text PDF

The μ-opioid receptor (μOR) is the primary drug target of opioid analgesics such as morphine and fentanyl. Activation of μORs in the central nervous system inhibits ascending pain signaling to the cortex, thereby producing analgesic effects. However, the clinical use of opioid analgesics is severely limited by adverse side effects, including respiratory depression, constipation, addiction, and the development of tolerance.

View Article and Find Full Text PDF

Introduction: This study aimed to evaluate the health perception of quality of life and function in patients with segmental bone defects (SBD) of the femur or tibia treated with the Induced Membrane Technique (IMT) and achieved bone healing and infection control.

Methods: This cross-sectional cohort study was conducted at a single referral center. Patients with infected SBD of the femur or tibia treated with IMT were included if they had at least 12 months of bone healing and no evidence of infection.

View Article and Find Full Text PDF